ANALYST-VERIFIED CLINICAL PIPELINE INSIGHTS AND COMMERCIAL VIABILITY
With IPD’s Clinical Development Insights subscription, you can evaluate every asset and trial in development with expert-verified results, measured against the same clinical bar payers use to decide access and reimbursement, from the first trial readout to launch day.
Get the complete picture on any indication: approved, and pipeline therapies, trial results and comparisons, benchmarks, Target Product Profiles, and commercial opportunity ratings, all in one place and kept current.
Executive Summary
Get IPD’s read on the market, treatment paradigm, competition, pipeline, and key implications for the indication.
​
Commercial Landscape
Compare marketed brands, biosimilars, and 505(b)(2) products on sales, rebates, cost, loss of exclusivity, and market access.
Pipeline Analytics
Track assets in development by phase, mechanism, and sponsor, with predicted approval timelines, catalysts, and assets to watch.
​
Trial Details & Insights
Compare standardized data points for every trial, with expert-verified results for every arm and timepoint.
Benchmarks & Target Product Profiles
Measure every result against standard-of-care ranges and physician thresholds, with a verdict and a Target Product Profile for each
Phase 2 and 3 asset.
​
IPD-Derived Cross-Trial Comparisons
When no head-to-head trials exist, IPD’s experts compare trials side by side on design, patients, efficacy, and safety, with clinical and commercial factors and pharmacist insights.
​
Commercial Pipeline Opportunity Ratings
View attribute-based ratings for Phase 2 and Phase 3 assets, mapped to a sales-potential tier calibrated to the indication.
​
Ready-to-Present Deliverables
Take the whole indication into a meeting with a sourced,
expert-verified, consultant-level deck, alongside Excel downloads for trial details, benchmarks, and Target Product Profiles.
Our Clinical Development Insights subscription also includes:
-
Platform access with coverage updated as data read out
-
Consultations with the IPD experts behind each indication
-
Excel export of trials, benchmarks, and Target Product Profiles
-
An executive presentation for every indication, refreshed each quarter
-
Alerts on changes to trials, benchmarks, Target Product Profiles, opportunity ratings, and the executive presentation